cdmo.directory
← Compare landing

AmbioPharm vs Cytovance Biologics

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAmbioPharmCytovance Biologics
SummaryFDA-inspected peptide API manufacturer offering GMP custom synthesis, process development, analytical method validation, and vaccine peptide manufacturing from preclinical through commercial scale.U.S.-based CDMO offering end-to-end biomanufacturing services for antibodies, recombinant proteins, vaccines, and other biologics modalities, with dedicated microbial and mammalian facilities and in-house cell line development capabilities.
Services
  • API Synthesis & Manufacturing
  • Peptide Manufacturing
  • Vaccine Manufacturing
  • Process Development
  • CMC Analytical Development
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • Microbial Fermentation
  • Vaccine Manufacturing
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • Peptide
  • Vaccine
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Peptide
  • Vaccine
Development capabilities
  • Analytical method development
  • Formulation development
  • Analytical method development
  • Formulation development
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Mammalian
  • Expression: Microbial
Locations
  • North Augusta, North Augusta, South Carolina, United States
  • Headquarters & Ingenuity Campus, Oklahoma City, Oklahoma, United States
CertificationsData not yet provided.Data not yet provided.

Find similar companies

AmbioPharm alternatives · Cytovance Biologics alternatives

Markdown mirror: /compare/ambiopharm/cytovance-biologics.md